Logo image of LGVN

LONGEVERON INC-A (LGVN) Stock Overview

NASDAQ:LGVN - US54303L2034 - Common Stock

0.818 USD
+0.04 (+4.97%)
Last: 8/26/2025, 8:00:02 PM
0.8173 USD
0 (-0.09%)
Pre-Market: 8/27/2025, 8:32:43 AM

LGVN Key Statistics, Chart & Performance

Key Statistics
52 Week High2.48
52 Week Low0.63
Market Cap17.01M
Shares20.80M
Float17.63M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.44
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO02-12 2021-02-12
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


LGVN short term performance overview.The bars show the price performance of LGVN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 -40

LGVN long term performance overview.The bars show the price performance of LGVN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of LGVN is 0.818 USD. In the past month the price decreased by -47.56%. In the past year, price decreased by -59.9%.

LONGEVERON INC-A / LGVN Daily stock chart

LGVN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.68 368.08B
AMGN AMGEN INC 13.28 155.90B
GILD GILEAD SCIENCES INC 14.83 142.38B
VRTX VERTEX PHARMACEUTICALS INC 22.86 99.27B
REGN REGENERON PHARMACEUTICALS 12.88 62.29B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 59.14B
ARGX ARGENX SE - ADR 76.39 43.34B
ONC BEONE MEDICINES LTD-ADR 6.24 36.72B
INSM INSMED INC N/A 27.94B
BNTX BIONTECH SE-ADR N/A 25.19B
NTRA NATERA INC N/A 22.74B
BIIB BIOGEN INC 8.54 20.04B

About LGVN

Company Profile

LGVN logo image Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. The company is headquartered in Miami, Florida and currently employs 25 full-time employees. The company went IPO on 2021-02-12. The Company’s lead investigational product is Lomecel-B, an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B has multiple potential mechanisms of action, encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. The firm is pursuing three pipeline indications: hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty. Lomecel-B development programs have received five distinct FDA designations: for the HLHS program - Orphan Drug designation, Fast Track designation, and Rare Pediatric Disease designation; and, for the AD program - Regenerative Medicine Advanced Therapy (RMAT) designation and Fast Track designation.

Company Info

LONGEVERON INC-A

1951 NW 7th Ave, Ste 520

Miami FLORIDA 33136 US

CEO: Geoff Green

Employees: 25

LGVN Company Website

LGVN Investor Relations

Phone: 13053027158

LONGEVERON INC-A / LGVN FAQ

What is the stock price of LONGEVERON INC-A today?

The current stock price of LGVN is 0.818 USD. The price increased by 4.97% in the last trading session.


What is the ticker symbol for LONGEVERON INC-A stock?

The exchange symbol of LONGEVERON INC-A is LGVN and it is listed on the Nasdaq exchange.


On which exchange is LGVN stock listed?

LGVN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for LONGEVERON INC-A stock?

9 analysts have analysed LGVN and the average price target is 7 USD. This implies a price increase of 755.72% is expected in the next year compared to the current price of 0.818. Check the LONGEVERON INC-A stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is LONGEVERON INC-A worth?

LONGEVERON INC-A (LGVN) has a market capitalization of 17.01M USD. This makes LGVN a Nano Cap stock.


How many employees does LONGEVERON INC-A have?

LONGEVERON INC-A (LGVN) currently has 25 employees.


What are the support and resistance levels for LONGEVERON INC-A (LGVN) stock?

LONGEVERON INC-A (LGVN) has a support level at 0.78 and a resistance level at 1.42. Check the full technical report for a detailed analysis of LGVN support and resistance levels.


Is LONGEVERON INC-A (LGVN) expected to grow?

The Revenue of LONGEVERON INC-A (LGVN) is expected to decline by -29.21% in the next year. Check the estimates tab for more information on the LGVN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy LONGEVERON INC-A (LGVN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LONGEVERON INC-A (LGVN) stock pay dividends?

LGVN does not pay a dividend.


What is the Price/Earnings (PE) ratio of LONGEVERON INC-A (LGVN)?

LONGEVERON INC-A (LGVN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.44).


What is the Short Interest ratio of LONGEVERON INC-A (LGVN) stock?

The outstanding short interest for LONGEVERON INC-A (LGVN) is 2.9% of its float. Check the ownership tab for more information on the LGVN short interest.


LGVN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

LGVN Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to LGVN. LGVN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LGVN Financial Highlights

Over the last trailing twelve months LGVN reported a non-GAAP Earnings per Share(EPS) of -1.44. The EPS increased by 83.52% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -122.67%
ROE -149.05%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%81.97%
Sales Q2Q%-32.48%
EPS 1Y (TTM)83.52%
Revenue 1Y (TTM)237.38%

LGVN Forecast & Estimates

9 analysts have analysed LGVN and the average price target is 7 USD. This implies a price increase of 755.72% is expected in the next year compared to the current price of 0.818.

For the next year, analysts expect an EPS growth of 71.17% and a revenue growth -29.21% for LGVN


Analysts
Analysts82.22
Price Target7 (755.75%)
EPS Next Y71.17%
Revenue Next Year-29.21%

LGVN Ownership

Ownership
Inst Owners8.77%
Ins Owners12.3%
Short Float %2.9%
Short Ratio0.46